US: Voyager Therapeutics and Pfizer Signs Gene Therapy Deal

Voyager Therapeutics, a gene therapy firm responsible for the development of the life-changing treatments along with the next-gen adeno-associated virus (AAV) platform technologies have announced the license option agreement with the company ‘Pfizer’ for the next-gen TRACER AAV Capsids for the purpose of enabling the Cardiovascular and Neurologic programs of gene therapy. With this deal, […]

Continue Reading